Navigation Links
Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis

BOSTON--(BUSINESS WIRE)--May 3, 2007 - Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that new data from the TOUCH Prescribing Program(TM) and TYGRIS safety study confirm the safety profile from previous clinical studies of TYSABRI(R) (natalizumab). Also presented at the 59th annual meeting of the American Academy of Neurology in Boston, MA were extension study data that showed that TYSABRI has a sustained treatment effect on clinical relapses and the risk of disability progression in multiple sclerosis (MS) patients treated for up to three years. The companies recently reported that as of mid-April 2007 approximately 12,500 patients have been prescribed TYSABRI worldwide. The companies estimate that in both commercial use and clinical trials, there are currently over 10,000 patients on TYSABRI therapy worldwide.

"The findings from the safety update combined with the data showing the sustained effect of TYSABRI in patients treated for up to three years, contribute to our evolving understanding of the utilization of this therapy as an important treatment option for people living with the debilitating effects of MS," said Paul O'Connor, MD, St. Michael's Hospital, Toronto, Ontario, Canada, lead investigator of the TYSABRI extension study.

TYSABRI Update

TYSABRI is available in the US through the TOUCH Prescribing Program. All prescribers, infusion sites and patients receiving TYSABRI are required to enroll in TOUCH. Safety information is also collected through ongoing clinical trials and registries, including STRATA, TYGRIS and the pregnancy registry. According to data available to the companies as of April 23, 2007, there have been no new reports of confirmed cases of progressive multifocal leukoencephalopathy (PML) or other serious opportunistic infections (OIs). The data confirm the safety profile from previous clinical studies of TYSABRI and will continue to exp
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:7/28/2014)... LEHIGH VALLEY, Pa. , July 28, 2014 /PRNewswire/ ... a reliable, uninterrupted supply of medical oxygen is vital ... company to technical innovations that not only improve the ... gas use. Air Products will highlight these systems—including systems ... systems that reduce oxygen loss—from August 4-5 at the ...
(Date:7/28/2014)... Research and Markets  has announced the addition of the ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... and pain in the human body,s joints such as wrists, ... of the tissues that surround the joints and in other ... slowly, usually just mild pain around the joints coupled with ...
(Date:7/28/2014)... 28, 2014  TNI BioTech, Inc. (OTCQB: TNIB) ... on the development, marketing and distribution of opioid-related ... proxy materials with the Securities and Exchange Commission ... Shareholders to be held on Thursday, September 4, ... record date for determining those shareholders eligible to ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Global Rheumatoid Arthritis Drugs Market 2014-2018 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... N.J., Dec. 13, 2010 PharmaNet Development Group, ... to pharmaceutical, biotechnology, generic drug and medical device ... launching two technology platforms – Initiator™ and PKS™ ... study timelines by accelerating data acquisition and the ...
... MedShape Solutions, Inc., the world,s leading developer of ... today announced a strategic investment and development agreement ... identifies innovative technology solutions to support the missions ... MedShape,s business is built on a technology platform ...
Cached Medicine Technology:PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics 2PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics 3MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community 2
(Date:7/28/2014)... 2014 Thousands of DePuy Pinnacle hip ... individuals who were allegedly injured by a metal-on-metal version ... forward in U.S. District Court, Northern District of Texas, ... on July 18, 2014, U.S. District Judge Ed Kinkeade ... Plaintiffs’ Steering Committee that sought the deposition of a ...
(Date:7/28/2014)... 28, 2014 Ticket Down is ... in Miami, FL at the Sun Life Stadium in ... football between Argentina and Brazil has is one that has ... more rivalries are forming on a consistent basis. The ... new height in the recent 2014 World Cup. To ...
(Date:7/28/2014)... Endurance runners are far more likely to die of ... a new study. The researchers pointed out ... are actually 10 times more likely to develop severe ... death of a young and apparently healthy person due ... often gets a lot more media attention. "This ...
(Date:7/28/2014)... Washington, NY (PRWEB) July 28, 2014 Parker ... many years fighting to ensure that the heroes of 9/11 ... Fund (VCF) has announced an important deadline. According to a ... were diagnosed with a covered cancer on or before October ... October 12, 2014. First responders and others who were allegedly ...
(Date:7/28/2014)... 2014 Bariatric Eating, a leading supplier ... it will be introducing three additional flavors to its ... The additional flavors include: , Inspire Summer Melon - ... Inspire Pomegranate Razz Berry -­ Pomegranate, razz and other ... cone , Bariatric Eating's Inspire protein powders ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2
... ... renewable resource. , ... 26, 2010 -- Laser and copier toners use over 146,000,000 gallons of oil per year. ... Forestry products, therefore, eliminating the need for petroleum products. The term bio-product is short ...
... New ... leading dermatologist Dr. David J. Goldberg. , ... (PRWEB) June 25, 2010 -- Dr. David J. Goldberg, a leading dermatologist and ... today that the practice will be offering the new eMatrix ™ treatment for acne ...
... in mice testes suggests a similar process that ... a Penn State College of Agricultural Sciences reproductive ... that signals stem cells to decide whether to ... self-renew and remain stem cells. By manipulating STAT3, ...
... Are ... Coker Offers an Answer. , ... Alpharetta, GA (Vocus) June 24, 2010 — Given the increase in patients across the ... specialties -- the role of advanced practitioners is evolving, but not to the liking of ...
... DecisionWise ... and Development. , ... (PRWEB) June 25, 2010 -- A new self-initiated 360-degree feedback survey ... System makes it possible for an individual to initiate his or her own personal ...
... renowned experts have assembled in Dubrovnik, Croatia to discuss ... in diagnostic techniques that will shape the future management ... cause of cancer-related death globally, and a leading ... "This HCC conference is a significant milestone ...
Cached Medicine News:Health News:Great Office Buys Announces the Addition of Elite Brand Bio-Based Toners to their Product Line 2Health News:Skin Laser and Surgery Specialists Offers New eMatrix™ Treatment for Acne Scarring 2Health News:Skin Laser and Surgery Specialists Offers New eMatrix™ Treatment for Acne Scarring 3Health News:Mechanism that may trigger degenerative disease identified 2Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 2Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 3Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 4Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 5Health News:Are Advanced Practitioners Stepping on the Practice Turf of Physicians? 6Health News:Self-Service 360-Degree Feedback Gives Managers Power Over Their Own Leadership Development 2Health News:International liver cancer congress provides possible solutions to reduce significant burden 2Health News:International liver cancer congress provides possible solutions to reduce significant burden 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: